<DOC>
	<DOCNO>NCT01247103</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability pharmacokinetics AZD4316 follow oral administration single multiple dos healthy volunteer .</brief_summary>
	<brief_title>Assessment Safety Pharmacokinetics Single Multiple Oral Doses AZD4316 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male female subject age 18 50 year suitable vein cannulation repeat venepuncture . Female subject must pregnant , must lactate must nonchildbearing potential ( i.e . must postmenopausal surgically sterile ) Male subject willing use barrier contraception i.e . condom spermicide , day dose least 3 month dose investigational product Have body mass index ( BMI ) 18 30 kg/m2 inclusive weigh least 50 kg 100 kg inclusive . Subjects healthy determine pre study medical history , physical examination , 12Lead ECG History clinically significant disease disorder , opinion investigator , may either put subject risk participation study , influence result subject 's ability participate study . Any clinically important abnormality rhythm , conduction morphology rest ECG , include change may interfere interpretation QTcF interval change . Current smoker , smoke use nicotine product within previous three month . History severe allergy/hypersensitivity ongoing clinically important allergy/hypersensitivity , judge investigator history hypersensitivity drug similar chemical structure class AZD4316 . Judgment investigator subject participate study ongoing recent ( ie , screening period ) minor medical complaint may interfere interpretation study data consider unlikely comply study procedure , restriction requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>healthy volunteer</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
</DOC>